Mount Sinai - PRIME — Linden, New Jersey

Mount Sinai - PRIME is a clinical research site located in Linden, New Jersey, United States 07036.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai - PRIME has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai - PRIME?

Mount Sinai - PRIME has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai - PRIME conducted?

Mount Sinai - PRIME has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is Mount Sinai - PRIME accredited by Crixeo Health?

Mount Sinai - PRIME has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai - PRIME?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.